Wockhardt Limited (NSE:WOCKPHARMA)
India
· Delayed Price · Currency is INR 1,515.00
+13.40 (0.89%)
Aug 14, 2025, 3:30 PM IST
Wockhardt Employees
Wockhardt had 2,296 employees as of March 31, 2025. The number of employees decreased by 90 or -3.77% compared to the previous year.
Employees
2,296
Change (1Y)
-90
Growth (1Y)
-3.77%
Revenue / Employee
13.21M INR
Profits / Employee
-535.71K INR
Market Cap
247.79B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Aurobindo Pharma | 26,015 |
Wockhardt News
- 6 days ago - Wockhardt Q1 Results: Shares drop 3% as EBITDA falls 20.9% YoY Rs 72 crore, revenue flat at Rs 739 - Business Upturn
- 4 weeks ago - Wockhardt shares jump 4% after exiting loss-making US generics business - Business Upturn
- 4 weeks ago - Wockhardt exits US generics business to focus on innovative portfolio - Business Upturn
- 3 months ago - Senores Pharmaceuticals acquires USFDA-approved ANDA for Enalapril Maleate Tablets from Wockhardt - Business Upturn
- 3 months ago - Senores Pharmaceuticals share price jumps 3% after company acquires ANDA for Topiramate tablets from Wockhardt - Business Upturn
- 3 months ago - Senores Pharmaceuticals acquires ANDA for Topiramate tablets from Wockhardt - Business Upturn
- 4 months ago - Wockhardt shares climb 3% as breakthrough antibiotic Zaynich™ saves US cancer patient with drug-resistant infection - Business Upturn
- 4 months ago - Wockhardt’s novel antibiotic Zaynich™ helps save US child cancer patient battling superbug infection - Business Upturn